The regulation of patent medicines in the United States and France.

B o t h the Un i t ed S t a t e s a n d F r a n c e h a v e developed sa f egua rds aga ins t t h e d i s t r i b u t i o n of u n r e g u l a t e d m e d i c a l r e m e d i e s . The p rocess by w h i c h these safe­ g u a r d s have been pu t in to effect h a s been very di f ferent in t h e t w o coun t r i e s , a n d ref lects a difference in a t t i t u d e t o w a r d t h e s t a t e ' s role in social r egu la t ion . The effect of t hese r egu la t ions on the l icensing of n e w d r u g s h a s also led t o a di f ferent a p p r o a c h to d r u g deve lopmen t a n d t e s t ing in t h e Uni ted S t a t e s a n d F r a n c e .